The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global remote patient monitoring market was valued at US$ 1.1 Billion in 2021.
We expect the global remote patient monitoring market to exhibit a CAGR of 16.1% during 2022-
The rising prevalence of various cardiovascular diseases, among the geriatric population who are
more susceptible to chronic conditions, represents one of the key factors driving the global remote
patient monitoring market.
The sudden outbreak of the COVID-19 pandemic has led to the growing adoption of remote patient
monitoring services, enabling health professionals to remotely monitor patients infected with the
coronavirus infection and improve the quality of medical care.
Based on the device type, the global remote patient monitoring market can be categorized into
blood pressure monitor, glucose monitor, heart rate monitor, pulse oximeters, respiratory monitor,
and others. Among these, heart rate monitor device holds the majority of the total market share.
Based on the application, the global remote patient monitoring market has been segmented into
cancer treatment, cardiovascular diseases treatment and monitoring, diabetes treatment, sleep
disorder treatment, weight management and fitness monitoring, and others. Currently,
cardiovascular diseases treatment and monitoring represent the largest market share.
Based on the end-use, the global remote patient monitoring market can be bifurcated into hospitals
and clinics, homecare settings, and others. Among these, hospitals and clinics currently account for
the majority of the global market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global remote patient monitoring market include Abbott
Laboratories, AMD Global Telemedicine Inc., BIOTRONIK SE & Co. KG, Boston Scientific Corporation,
Dexcom, Inc., GE Healthcare Inc. (Danaher Corporation), Honeywell International Inc., Koninklijke
Philips N.V., Medtronic Inc., Nihon Kohden Corporation, OSI Systems Inc., Roche Holding AG, etc.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at